Clinical Research in Cardiology

Article	Citations
Correction to: An unintentional complication during an intentional procedure—Sinus of Valsalva laceration during BASILICA	73
Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure	60
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial	48
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry	45
Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses	43
Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction	43
Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy	42
Association of daily physical activity with pulmonary artery pressure in HFpEF and HFmrEF NYHA class III patients: a pilot trial—feasibility and first results	41
Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort	37
Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography	32
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry	30
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry	28
Remote proctoring for high-risk coronary interventions with mechanical circulatory support during COVID-19 pandemic and beyond	27
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial	27
Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection	27
Lessons learned from catheter ablation of ventricular arrhythmias in patients with a fully magnetically levitated left ventricular assist device	26
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy	26
Drug overdose and the risk of cardiovascular diseases: a nested case–control study	24
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic	24
Heart failure burden and care among cardiology inpatients: insights from the Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study	24
Venting during venoarterial extracorporeal membrane oxygenation	24
Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction	23
Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial	23
Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure	23
Outcome of patients with idiopathic ventricular fibrillation and correlation with ECG markers of early repolarization	23

Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry	23
Periinterventional inflammation and blood transfusions predict postprocedural delirium after percutaneous repair of mitral and tricuspid valves	22
Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices	22
Frailty, periinterventional complications and outcome in patients undergoing percutaneous mitral and tricuspid valve repair	22
Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials	21
Long-term outcome of patients presenting with myocardial injury or myocardial infarction	21
Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)	20
The impact of epicardial adipose tissue in patients with acute myocardial infarction	20
Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndrome: a meta-analysis	19
Large extracellular vesicles in the left atrial appendage in patients with atrial fibrillation—the missing link?	19
Non-specific myocardial fibrosis in young competitive athletes: clinical significance and risk prediction by a powerful machine learning-based model	19
Normal age- and sex-based values of right ventricular free wall and four-chamber longitudinal strain by speckle-tracking echocardiography: from the Copenhagen City heart study	19
The relationship between serum potassium levels and cardiac arrhythmias in left ventricular assist device (LVAD) recipients: a comprehensive analysis and prognostic evaluation	19
The effect of a smaller spacer in the PASCAL Ace on residual mitral valve orifice area	19
Controlling my genome with my smartphone: first clinical experiences of the PROMISE system	19
Impact of body mass index in patients with tricuspid regurgitation after transcatheter edge-to-edge repair	19
Echocardiographic assessment of left ventricular volumes: a comparison of different methods in athletes	19
Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison	18
Aortic regurgitation is associated with African American and Asian race, smoking, renal disease, and numerous autoimmune diseases in addition to traditional cardiovascular risk factors but has lower r	18
Correction: The influence of lipoprotein(a) on aortic valve calcification in patients undergoing transcatheter aortic valve replacement	18
TAVI in patients with low-flow low-gradient aortic stenosis–short-term and long-term outcomes	18
Antithrombotic strategy following valve-in-valve transcatheter aortic valve replacement. A German Statutory Health Claims data analysis	18
Comparison of contemporary transcatheter heart valve prostheses: data from the German Aortic Valve Registry (GARY)	17
A systematic review and meta-analysis of the use of drug-coated balloon angioplasty for treatment of both de novo and in-stent coronary chronic total occlusions	17
Characteristics and outcomes of angiovac-assisted debulking of intracardiac masses, thrombi, and endocarditis	17
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications	17
Infective endocarditis after isolated aortic valve replacement: comparison between catheter-interventional and surgical valve replacement	17
Comment on: GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis	17
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide	16
Right ventricular to pulmonary artery coupling in patients with different types of aortic stenosis undergoing TAVI	16
Arrhythmias and laboratory abnormalities after an electrical accident: a single-center, retrospective study of 333 cases	16
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment	15
The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry	15
Quantitative flow ratio or angiography for the assessment of non-culprit lesions in acute coronary syndromes, a randomized trial	14
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry	14
NET burden in left atrial blood is associated with biomarkers of thrombosis and cardiac injury in patients with enlarged left atria	14
Impact of implantation depth on outcomes of new-generation balloon-expandable transcatheter heart valves	14
The impact of myocardial injury on outcomes in TAVI patients	14
The pathophysiological approach: the best for phenotyping patients with pulmonary arterial hypertension: reply	14
Cost-effectiveness of a multidimensional post-discharge disease management program for heart failure patients—economic evaluation along a one-year observation period	14
Fluid balance during acute phase extracorporeal cardiopulmonary resuscitation and outcomes in OHCA patients: a retrospective multicenter cohort study	14
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair	14
Spontaneous blood pressure reduction of previously hypertensive patients as a symptom of central pulmonary artery embolism	13
Endothelial activation and stress index (EASIX) in coronary artery disease: a simplified measure as a promising biomarker	13
ACEF score and lactate: lifeline predictors in endocarditis valve procedures: insights from a single-center study	13
Prognostic impact of cancer history in patients undergoing transcatheter mitral valve repair	13
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities	13
Correction to: Response to Letter to the editors of Hopkins et al.: Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity: the numbers do not add up	13
Prognostic value of heart rate and oxygen pulse response in heart failure with left ventricular ejection fraction over 40%	13
Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females	13

New avenues for the assessment of stable ischemic heart disease	13
Age period cohort analysis of rheumatic heart disease in high-income countries	13
Correction to: Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience	12
Reply to La Via and colleagues	12
Publisher Correction: Circumstances in a young German cohort with sudden cardiac arrest: systematic insights and implications	12
High prevalence of reduced fertility and use of assisted reproductive technology in a German cohort of patients with peripartum cardiomyopathy	12
Incidence and clinical impact of renal failure and bleeding following transcatheter tricuspid valve annuloplasty	12
Left atrial appendage occlusion: trends in demographics and in-hospital outcomes—a German nationwide analysis	12
Procedural success in transaxillary transcatheter aortic valve implantation according to type of transcatheter heart valve: results from the multicenter TAXI registry	12
Global longitudinal strain in long-term risk prediction after acute coronary syndrome: an investigation of added prognostic value to ejection fraction	12
Reply to “Comment on: GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis”	12
Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair	11
Impact of left atrial appendage occlusion device position on potential determinants of device-related thrombus: a patient-specific in silico study	11
SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring	11
Heart rate variability: reference values and role for clinical profile and mortality in individuals with heart failure	11
Long-term outcomes with medical therapy, transcatheter repair, or surgery for isolated tricuspid regurgitation: a systematic review and network meta-analysis	11
Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation	11
Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis	11
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension	11
RAS inhibitors and renal and general mortality in patients with heart failure supported by left ventricular assist devices: a registry study	11
Blood pressure changes during tenofovir-based antiretroviral therapy among people living with HIV in Lilongwe, Malawi: results from the prospective LighTen Cohort Study	11
Effect of eplerenone in acute heart failure using a win ratio approach	10
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART)	10
Atherosclerosis is an inflammatory disease: treat it as such!	10
Myocardial work in chronic kidney disease: insights from the CPH-CKD ECHO Study	10
Five-year-outcome of new-onset perioperative atrial fibrillation after left atrial appendage amputation concomitant with cardiac surgery	10
Prior hospitalizations as a predictor of prognosis in heart failure with mildly reduced ejection fraction	10
Towards automatic classification of cardiovascular magnetic resonance Task Force Criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy	10
Robustness of tricuspid regurgitation reduction at 1 year following edge-to-edge repair for primary tricuspid regurgitation	10
Catheter ablation of supraventricular tachycardia in patients with and without structural heart disease: insights from the German ablation registry	10
Correction to: The impact of epicardial adipose tissue in patients with acute myocardial infarction	10
Risk and effect modifiers for poor glycemic control among the chinese diabetic adults on statin therapy: the kailuan study	10
Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis	10
LAA occlusion is effective and safe in very high-risk atrial fibrillation patients with prior stroke: results from the multicentre German LAARGE registry	10
Causal association between lipoproteins and risk of coronary artery disease—a systematic review and meta-analysis of Mendelian randomization studies	10
Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI	10
Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: data from PREVEND	10
Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction	10
Comparison of a novel self-expanding transcatheter heart valve with two established devices for treatment of degenerated surgical aortic bioprostheses	10
Publisher Correction: Respiratory exchange ratio overshoot during exercise recovery: a promising prognostic marker in HfrEF	10
Genetic and modifiable risk factors combine multiplicatively in common disease	9
Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials	9
New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysis	9
The role of cardiac magnetic resonance in sports cardiology: results from a large cohort of athletes	9
Short- and long-term outcomes of patients with active cancer presenting with an acute coronary syndrome	9
Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function	9
Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk	9
Depressive symptoms in patients after primary and secondary prophylactic ICD implantation	9
Comparison of Arctic Front Advance Pro and POLARx cryoballoons for ablation therapy of atrial fibrillation: an intraprocedural analysis	9
Absence of chest discomfort in type 1 NSTEMI patients: predictors and impact on outcome	9
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves	9
Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis	9
Right ventricular function and dimensions in patients undergoing transcatheter aortic valve replacement assessed by three-dimensional echocardiography	9
Comparison of plug-based versus suture-based vascular closure for large-bore arterial access: a collaborative meta-analysis of observational and randomized studies	9
Safety and feasibility of early discharge after transcatheter aortic valve implantation with ACURATE Neo—the POLESTAR trial	9
Investigating procedural safety: comparative analysis of rotational atherectomy and modified balloon angioplasty	9
Sex-related hormonal variances and clinical outcomes in TAVR patients	9
A novel score to predict in-hospital mortality for patients with acute coronary syndrome and out-of-hospital cardiac arrest: the FACTOR study	9
Correction: Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial	9
Symptom burden, psychosocial distress and palliative care needs in heart failure – A cross-sectional explorative pilot study	9
Personalized diagnosis in suspected myocardial infarction	8
Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study	8
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry	8
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists	8
Editorial comment: echocardiography in atrial fibrillation: overcoming challenges and embracing innovations	8
German Cardiac Arrest Registry (G-CAR)—results of the pilot phase	8
Effect of periprocedural furosemide-induced diuresis with matched isotonic intravenous hydration in patients with chronic kidney disease undergoing transcatheter aortic valve implantation	8
Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial	8
Comment on Grundmann et al. “Prognostic impact and diagnostic value of invasively derived hemodynamic measures in patients with severe aortic stenosis undergoing TAVI”	8
Establishing a cardiac training group for patients with heart failure: the “HIP-in-Würzburg” study	8
Very early infective endocarditis after transcatheter aortic valve replacement	8
A 39-year-old women with newly diagnosed ALCAPA syndrome during pregnancy	8
A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2	8
Letter to the editor: reply	8
Angiography-derived physiological patterns of coronary artery disease: implications with post-stenting physiology and long-term clinical outcomes	8
Association between stress hyperglycemia on admission and unfavorable neurological outcome in OHCA patients receiving ECPR	8
Associations between kidney function and outcomes of comprehensive cardiac rehabilitation in patients with heart failure	7
Treatment of patients with multiple organ dysfunction syndrome (MODS) with an electromagnetic field coupled to biorhythmically defined impulse configuration: the MicrocircMODS study	7
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications	7
Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: a retrospective single-center study	7

Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients	7
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination	7
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial	7
Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020	7
Cardiac sarcoidosis in patients with recurrent ventricular arrhythmias refractory to endocardial ablation	7
Balloon technologies for pulmonary vein isolation—12-month outcome and comparison of the novel radiofrequency balloon with the cryoballoon in patients with paroxysmal atrial fibrillation	7
Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure	7
GRACE scores or high-sensitivity troponin for timing of coronary angiography in non-ST-elevation acute coronary syndromes	7
Impact of HAS-BLED Score on outcome after percutaneous left atrial appendage closure: insights from the German Left Atrial Appendage Occluder Registry LAARGE	7
Healthcare resource utilisation and associated costs after low-risk pulmonary embolism: pre-specified analysis of the Home Treatment of Pulmonary Embolism (HoT-PE) study	7
Heyde syndrome: prevalence and outcomes in patients undergoing transcatheter aortic valve implantation	7
Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization	7
Differences in clinical features and 1-year outcomes of patients with heart failure and reduced, mildly reduced, and preserved ejection fraction in a contemporary cohort: is the clinical profile chang	7
Association of systemic inflammation with shock severity, 30-day mortality, and therapy response in patients with cardiogenic shock	7
Impact of atrial fibrillation pattern on outcomes after left atrial appendage closure: lessons from the prospective LAARGE registry	7
Randomized non-inferiority TrIal comParing reverse T And Protrusion versus double-kissing and crush Stenting for the treatment of complex left main bifurcation lesions	7
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial	7
Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry	7
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study	7
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation	7
VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients	6
Deferral of non-emergency cardiac procedures is associated with increased early emergency cardiovascular hospitalizations	6
Respiratory exchange ratio overshoot during exercise recovery: a promising prognostic marker in HFrEF	6
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany	6
Thrombotic ST-segment elevation myocardial infarction caused by a caseous mitral annular calcification	6
German Cardiac Arrest Registry: rationale and design of G-CAR	6
Successful baroreflex activation therapy in a case of therapy-resistant renovascular hypertension	6
Metabolically ‘extremely unhealthy’ obese and non-obese patients with diabetes and the risk of cardiovascular events: a French nationwide cohort study	6
Comparison of long-term outcome in patients with in-stent restenosis treated with intravascular lithotripsy or with modified balloon angioplasty	6
COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis	6
Cumulative incidence and risk factors of myocardial infarction during 20 years of follow-up: comparing two cohorts of middle-aged men born 30 years apart	6
Effects of face masks on performance and cardiorespiratory response in well-trained athletes	6
Analysis of YouTube, myocarditis and COVID-19: correspondence	6
Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany	6
Letter to the editor: “Cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease”	6
Epicardial ventricular tachycardia ablation: safety and efficacy of access and ablation using low-iodine content	6
Feasibility and outcome of third-generation transcatheter aortic valve implantation in patients with extra-large aortic annulus	6
Echocardiographic left atrial stiffness index predicts high left ventricular filling pressures in patients with acute heart failure: an observational study	6
Impact of common rhythm disturbances on echocardiographic measurements and interpretation	6
Response to the Letter to the editor: “cardiovascular magnetic resonance reveals myocardial involvement in patients with active stage of inflammatory bowel disease” (CRCD-D-24–01694)	6
Comparison of transcatheter leaflet-approximation and direct annuloplasty in tricuspid regurgitation	6
Statins for primary prevention of cardiovascular disease in Germany: benefits and costs	6
Tafamidis for cardiac transthyretin amyloidosis: application in a real-world setting in Germany	6
One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public hospitals in Spain between 2016 and	6
Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study	6
Differential effects of anaemia and iron deficiency on long-term outcomes following transcatheter edge-to-edge repair in degenerative vs. secondary mitral regurgitation: results from a large single-ce	6
Correction to: The Zwolle experience with left bundle branch area pacing using stylet-driven active fixation leads	6
Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study design	6